glp 1 boost by happyself GLP-1 | Active Products GLP-1 COMPANION

Maintain adequate fluid intake and seek medical advice if unable to stay hydrated

The platform works well for patients with stable metabolic profiles and minimal comorbidities requiring intensive clinical monitoring

GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation

in addition to GLP-1 and GIP, it also mimics the hormone glucagon

So, for example, I often will ask people to intentionally not come into the medication on a very full gut or stomach because the minute the medication goes in and slows everything down, they may end up feeling sicker than they need [inaudible 00:19:19]

The retatrutide availability timeline depends on ongoing clinical trials and regulatory review: Current status: Multiple phase 3 trials (TRIUMPH program) ongoing Phase 3 primary completion: Expected through mid-year NDA submission: Eli Lilly expected to submit to FDA in late future FDA review period: Approximately 10 months after submission Estimated approval: Potentially late next year at earliest Commercial launch: Could follow shortly after approval It is important to note that Eli Lilly has not announced an official filing timeline